Department of Pediatric Endocrinology, Mehta Multispeciality Hospitals India Pvt Ltd, India.
Department of Neonatology, Mehta Multispeciality Hospitals India Pvt, India.
Pediatr Endocrinol Diabetes Metab. 2021;27(2):82-86. doi: 10.5114/pedm.2021.105295.
Paucity of data on hypothyroidism in Indian preterms. Aim of the study: To describe the prevalence, aetiology, and experience with screening for primary hypothyroidism in preterm babies.
A prospective observational study conducted for 3 years in a tertiary care unit, where all babies born < 37 weeks screened by heel prick for Thyroid Stimulating Hormone (TSH) were included. All screen positive cases (TSH ≥ 6 µIU/ml) underwent venous testing immediately; venous TSH ≥ 20 or Free T4 < 0.9 ng/dl was considered as confirmed positive. All babies underwent venous testing at term. Etiological testing was performed where feasible. Confirmed cases were initiated on thyroxine therapy and followed up.
1167 preterm babies presented during the study period. 1147 (98%) underwent TSH screening and 17 (1.4%) were screen positive; 15 babies underwent confirmatory venous test. Of these 15 babies, 2 were confirmed and started on therapy. The remaining 13 babies underwent retest venous sample at term, and 8 of these were confirmed cases. Of the screen-negative babies, 94% underwent repeat venous testing at term/ prior to discharge. Five were confirmed to have congenital hypothyroidism. Thus, the prevalence of congenital hypothyroidism was 1 in 77 preterm babies. No correlation was observed between screening TSH and venous TSH (p > 0.05). Aetiological evaluation in 8 babies revealed secondary to maternal antibody in 4 cases (50%) and permanent thyroid defects in 4 cases (50%).
We observed a high prevalence (1 in 77), need for repeat venous testing, irrespective of initial screening, and significant permanent congenital hypothyroidism (50%) in our series.
印度早产儿中甲状腺功能减退症的数据不足。目的:描述早产儿原发性甲状腺功能减退症的患病率、病因和筛查经验。
在一家三级保健单位进行了为期 3 年的前瞻性观察研究,所有出生时<37 周的婴儿均通过足跟采血筛查促甲状腺激素(TSH)。所有筛查阳性(TSH≥6μIU/ml)的病例均立即进行静脉检测;静脉 TSH≥20或游离 T4<0.9ng/dl 被认为是确诊阳性。所有婴儿均在足月时进行静脉检测。在可行的情况下进行病因检测。确诊病例开始使用甲状腺素治疗并进行随访。
研究期间有 1167 例早产儿就诊。1147 例(98%)进行了 TSH 筛查,17 例(1.4%)筛查阳性;15 例婴儿进行了确诊性静脉检测。这 15 例婴儿中,有 2 例确诊并开始治疗。其余 13 例婴儿在足月时进行了重复静脉样本检测,其中 8 例为确诊病例。在筛查阴性的婴儿中,94%在足月/出院前进行了重复静脉检测。5 例被确诊为先天性甲状腺功能减退症。因此,早产儿先天性甲状腺功能减退症的患病率为 1/77。筛查 TSH 与静脉 TSH 之间无相关性(p>0.05)。对 8 例婴儿进行病因评估发现,有 4 例(50%)是由于母体抗体引起的继发性,4 例(50%)是永久性甲状腺缺陷。
我们观察到本系列中存在较高的患病率(1/77)、需要重复静脉检测、不论初始筛查结果如何,以及相当比例的永久性先天性甲状腺功能减退症(50%)。